List of works - Einar G Gudlaugsson

A protein profile study to discriminate CIN lesions from normal cervical epithelium.

scientific article

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

scientific article published on 11 March 2008

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis

scientific article published on 01 December 2018

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

scientific article published on September 3, 2010

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma ⬇️

scientific article published on May 6, 2011

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

scientific article

Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.

scientific article published in January 2007

Cervical intraepithelial neoplasia grade 3 lesions can regress

scientific article published on December 2007

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

scientific article

Comparison of apolipoprotein D determination methods in breast cancer

scientific article published on 01 March 2008

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3

scientific article published on 10 August 2011

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer ⬇️

scientific article published on September 11, 2012

Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3 ⬇️

scientific article published on September 13, 2012

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

scientific article published on February 11, 2011

Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours ⬇️

scientific article published on 01 April 2013

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients

scientific article published on 20 July 2020

Evaluation of 5 different labeled polymer immunohistochemical detection systems

scientific article

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant! ⬇️

scientific article published on December 28, 2010

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

scientific article published on 08 November 2019

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression

scientific article

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

scientific article

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression

scientific article

Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ

scientific article published on 30 January 2008

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

scientific article published on 04 December 2019

Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.

scientific article

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

scientific article published on 05 May 2020

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer

scientific article published on 02 June 2020

Molecular biomarkers in endometrial hyperplasias predict cancer progression ⬇️

scientific article published on February 16, 2011

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

scientific article

Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis

scientific article

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder

scientific article published on 26 March 2014

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer

scientific article published on April 1, 2013

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years

scientific article published on 4 March 2008

Prognostic relevance of androgen receptor detection in operable breast cancer

scientific article

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas

scientific article published on 14 August 2019

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer

scientific article

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

scientific article

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

scientific article published on 01 July 2009

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder

scientific article published on 07 January 2014

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3 ⬇️

scientific article published on 01 April 2011

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer ⬇️

scientific article published on 08 July 2012

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer

scientific article

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer

scientific article published on 30 October 2008

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent

scientific article published on 15 November 2006

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

scientific article published on February 1, 2011

The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer

scientific article published in January 2009

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

scientific article

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers ⬇️

scientific article published on November 7, 2012

List of works by Einar G Gudlaugsson

A protein profile study to discriminate CIN lesions from normal cervical epithelium.

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma ⬇️

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.

Cervical intraepithelial neoplasia grade 3 lesions can regress

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

Comparison of apolipoprotein D determination methods in breast cancer

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer ⬇️

Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3 ⬇️

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours ⬇️

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients

Evaluation of 5 different labeled polymer immunohistochemical detection systems

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant! ⬇️

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression

Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer

Molecular biomarkers in endometrial hyperplasias predict cancer progression ⬇️

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years

Prognostic relevance of androgen receptor detection in operable breast cancer

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3 ⬇️

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer ⬇️

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers ⬇️

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients